Jump to Content Jump to Main Navigation

Volume 17 (2019): Issue 4 (Apr 2019)

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

Cover Journal of the National Comprehensive Cancer Network

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
- Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
  
  By: Daniel G. Coit, John A. Thompson, Mark R. Albertini, Christopher Barker, William E. Carson III, Carlo Contreras, Gregory A. Daniels, Dominick DiMaio, Ryan C. Fields, Martin D. Fleming, Morganna Freeman, Anjela Galan, Brian Gastman, Valerie Guild, Douglas Johnson, Richard W. Joseph, Julie R. Lange, Sameer Nath, Anthony J. Olszanski, Patrick Ott, Aparna Priyanath Gupta, Merrick I. Ross, April K. Salama, Joseph Skitzki, Jeffrey Sosman, Susan M. Swetter, Kenneth K. Tanabe, Evan Wuthrick, Nicole R. McMillian and Anita M. Engh
  
  Pages: 367–402
NCCN Guidelines® Insights
- NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019
  
  Featured Updates to the NCCN Guidelines
  
  By: Al B. Benson III, Michael I. D’Angelica, Daniel E. Abbott, Thomas A. Abrams, Steven R. Alberts, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Daniel Brown, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, William Hawkins, Renuka Iyer, Rojymon Jacob, Andreas Karachristos, R. Kate Kelley, Robin Kim, Manisha Palta, James O. Park, Vaibhav Sahai, Tracey Schefter, Jason K. Sicklick, Gagandeep Singh, Davendra Sohal, Stacey Stein, G. Gary Tian, Jean-Nicolas Vauthey, Alan P. Venook, Lydia J. Hammond and Susan D. Darlow
  
  Pages: 302–310
Oncology Watch
- The Time Has Come!
  
  By: Margaret Tempero
  
  Pages: 295
Correspondence
- Letter to the Editor: When Expertly Applied, ESMO-MCBS and ASCO Net Health Benefit Scores Usually Agree
  
  By: Nathan I. Cherny, Elisabeth G. E. de Vries and Richard L. Schilsky
  
  Pages: xxi
Molecular Insights in Patient Care
- Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors
  
  By: Jay Gong, Jeffrey P. Gregg, Weijie Ma, Ken Yoneda, Elizabeth H. Moore, Megan E. Daly, Yanhong Zhang, Melissa J. Williams and Tianhong Li
  
  Pages: 297–301
Original Research
Departments
- Oncology Research Program
  
  Pages: xiii
- NCCN News
  
  Pages: xvi–xviii